Back to Search Start Over

Transcranial direct current stimulation (tDCS) reverts behavioral alterations and brainstem BDNF level increase induced by neuropathic pain model: Long-lasting effect

Authors :
Iraci Lucena da Silva Torres
Lauren Naomi Spezia Adachi
Alexandre S. Quevedo
Vanessa Leal Scarabelot
Wolnei Caumo
Liciane Fernandes Medeiros
Joanna Ripoll Rozisky
Andressa de Souza
Carla de Oliveira
Felipe Fregni
Stefania Giotti Cioato
Rafael Vercelino
Paulo Roberto Stefani Sanches
Paulo Ricardo Marques Filho
Source :
Progress in neuro-psychopharmacologybiological psychiatry. 64
Publication Year :
2015

Abstract

IntroductionNeuropathic pain (NP) is a chronic pain modality that usually results of damage in the somatosensory system. NP often shows insufficient response to classic analgesics and remains a challenge to medical treatment. The transcranial direct current stimulation (tDCS) is a non-invasive technique, which induces neuroplastic changes in central nervous system of animals and humans. The brain derived neurotrophic factor plays an important role in synaptic plasticity process. Behavior changes such as decreased locomotor and exploratory activities and anxiety disorders are common comorbidities associated with NP.ObjectiveEvaluate the effect of tDCS treatment on locomotor and exploratory activities, and anxiety-like behavior, and peripheral and central BDNF levels in rats submitted to neuropathic pain model.MethodsRats were randomly divided: Ss, SsS, SsT, NP, NpS, and NpT. The neuropathic pain model was induced by partial sciatic nerve compression at 14days after surgery; the tDCS treatment was initiated. The animals of treated groups were subjected to a 20minute session of tDCS, for eight days. The Open Field and Elevated Pluz Maze tests were applied 24h (phase I) and 7days (phase II) after the end of tDCS treatment. The serum, spinal cord, brainstem and cerebral cortex BDNF levels were determined 48h (phase I) and 8days (phase II) after tDCS treatment by ELISA.ResultsThe chronic constriction injury (CCI) induces decrease in locomotor and exploratory activities, increases in the behavior-like anxiety, and increases in the brainstem BDNF levels, the last, in phase II (one-way ANOVA/SNK, P

Details

ISSN :
18784216
Volume :
64
Database :
OpenAIRE
Journal :
Progress in neuro-psychopharmacologybiological psychiatry
Accession number :
edsair.doi.dedup.....0ebcf5a24de8e2a2e27ad3c8d09aaa4f